VXRT: Vaxart Inc Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 876.66
Enterprise Value ($M) 876.66
Book Value ($M) 176.24
Book Value / Share 1.44
Price / Book 4.97
NCAV ($M) 145.79
NCAV / Share 1.19
Price / NCAV 6.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.87
Return on Equity (ROE) -2.49

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 15.07

Balance Sheet (mrq) ($M)
Current Assets 175.42
Assets 205.87
Liabilities 29.63
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -30.17
Net Income -32.22
Earnings Per Share Basic And Diluted -0.36
Earnings Per Share Diluted -0.36
Earnings Per Share Basic -0.36

Cash Flow Statement (mra) ($M)
Cash From Operations -23.75
Cash from Investing -1.22
Cash from Financing -1.22

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-11 13G State Street Corp 8.63 33,071.66
06-30 13D/A Armistice Capital, Llc 0.20 -99.13

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-05-06 10-Q Quarterly Report – FORM 10-Q
2021-02-25 10-K Annual Report – FORM 10-K
2020-11-12 10-Q Quarterly Report – FORM 10-Q
2020-08-06 10-Q Quarterly Report – FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-06-11 38,819,151 104,095,700 37.29
2021-06-10 886,406 5,264,800 16.84
2021-06-09 1,706,585 9,470,700 18.02
2021-06-08 1,494,679 6,561,100 22.78
2021-06-07 1,151,152 8,593,400 13.40

(click for more detail)

(click for list of largest short owners)

Similar Companies
VTGN – Vistagen Therapeutics Inc VTRS – Viatris Inc
VTVT – vTv Therapeutics Inc VYGR – Voyager Therapeutics Inc
VYNE – Vyne Therapeutics Inc


Financial data and stock pages provided by
Fintel.io